Sotoxen 120 mg (Sotorasib)

Sotoxen 120 mg (Sotorasib)

Sotoxen 120 mg (Sotorasib) is a breakthrough oral oncology medication used for the targeted treatment of non-small cell lung cancer (NSCLC) with a specific genetic mutation. It represents a significant advancement in precision medicine as a first-in-class inhibitor for a mutation previously considered "undruggable."

This medication is manufactured by Everest Pharmaceuticals Ltd., a leading pharmaceutical company in Bangladesh, and is supplied globally by Mediaid Pharmacy. We are committed to providing patients and healthcare professionals worldwide with access to genuine, high-quality cancer treatments. This product is registered in Bangladesh and available for global shipping.

What is Sotoxen 120 mg (Sotorasib)?

Sotoxen contains the active ingredient Sotorasib, which is a KRAS inhibitor. It specifically targets a mutated form of the KRAS protein known as KRAS G12C.

In healthy cells, the KRAS protein acts like an on/off switch for cell growth. In cancers with the KRAS G12C mutation, this switch gets stuck in the "on" position, causing cancer cells to grow and divide uncontrollably. Sotoxen works by binding to the mutated KRAS G12C protein and locking it in the "off" position, thereby stopping tumor growth and signaling.

Indications for Use

Sotoxen 120 mg is indicated for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC).

It is specifically prescribed for patients who have received at least one prior systemic therapy. The presence of the KRAS G12C mutation must be confirmed by an FDA-approved or validated test before initiating treatment.

Dosage & Administration

Sotoxen comes in 120 mg tablets. The dosage is typically determined by your oncologist based on established protocols.

• Standard Dosage: The recommended dosage is often 960 mg (eight 120 mg tablets) taken orally once daily.
• Administration: Take the tablets at the same time each day.
• With or Without Food: Sotoxen can be taken with or without food.
• Swallow Whole: Swallow the tablets whole. Do not chew, crush, or split the tablets.

Always follow the specific dosage instructions provided by your qualified oncologist, as dose modifications may be required.

Manufacturer – Everest Pharmaceuticals Ltd.

Everest Pharmaceuticals Ltd. is a renowned manufacturer in the pharmaceutical industry, known for its high-tech production of specialized oncology drugs. With facilities that comply with international Good Manufacturing Practices (GMP), Everest ensures that Sotoxen is produced to the highest standards of safety, purity, and potency.

Supplier – Mediaid Pharmacy

Mediaid Pharmacy is your trusted global supplier and distributor of specialized oncology medicines, including Sotoxen 120 mg. We are dedicated to bridging the gap in global healthcare by ensuring patients have access to essential medications.

Mediaid Pharmacy is known for:

• Worldwide Shipping: We securely ship medications to patients, pharmacies, and hospitals across the globe.
• Guaranteed Authenticity: We source Sotoxen directly from Everest Pharmaceuticals to ensure you receive 100% genuine products.
• Patient-Centric Service: Our professional team provides dedicated support and ensures a seamless, confidential ordering process.
• Competitive Pricing: We strive to offer affordable solutions for advanced cancer care.

Why Choose Sotoxen 120 mg from Mediaid Pharmacy?

• Targeted Innovation: Specifically targets the KRAS G12C mutation, offering hope where few options existed before.
• Oral Convenience: An oral tablet therapy that can be taken at home.
• High-Quality Manufacturing: Produced by Everest Pharmaceuticals under strict quality control.
• Global Availability: Distributed efficiently by Mediaid Pharmacy with reliable shipping options.

Frequently Asked Questions (FAQs)

Q: How do I know if I have the KRAS G12C mutation?
A: Your doctor will perform a biomarker test (genomic profiling) on a tumor sample or blood sample to verify if your cancer carries this specific mutation.

Q: How many tablets do I take at once?
A: The standard starting dose is often 8 tablets (totaling 960 mg) once daily, but you must strictly follow the prescription given by your doctor.

Q: How is the product packaged?
A: Sotoxen 120 mg is available in a bottle containing 56 tablets.

Conclusion

Sotoxen 120 mg (Sotorasib) is a pioneering targeted therapy for patients with KRAS G12C-mutated NSCLC. By directly inhibiting the mutated protein driving the cancer, it offers a vital treatment option. Manufactured by Everest Pharmaceuticals and supplied by Mediaid Pharmacy, it provides a high-quality and accessible solution for patients worldwide.

Contact Us to Order or Inquire

For the latest pricing, bulk orders, or to speak with our pharmacy team about Sotoxen 120 mg (Sotorasib), please contact us. We are available 24/7 to support your healthcare needs.

WhatsApp/WeChat: +8801773428128